ליריקה 150 מג
pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 150 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.
ליריקה 200 מג
pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 200 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.
ליריקה 300 מג
pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 300 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.
ליריקה 225 מג
pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 225 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults.management of fibromyalgia.
וימפט 50 מג
neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 50 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.
וימפט 100 מג
neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 100 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.
וימפט 150 מג
neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 150 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.
וימפט 200 מג
neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 200 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.
וימפט 10 מ"ג/מ"ל
cts ltd - lacosamide 10 mg / 1 ml - solution for infusion - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.vimpat solution for infusion is an alternative for patients when oral administration is temporary not feasible.
טרובלט 50 מ"ג
glaxo smith kline (israel) ltd - retigabine 50 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.